{"entity":{"type":"insider","cik":"0001965808","url":"/insider/0001965808","json_url":"/insider/0001965808.json","name":"Delaet Ingrid","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":35,"n_filings":23,"first":"2023-08-23","last":"2026-07-13","span_basis":"filed_date"},"name_variants":[{"name":"Delaet Ingrid","source":"filing","n_filings":23,"first_seen":"2023-08-23","last_seen":"2026-07-13"}],"transactions":[{"id":5772368,"accession":"0001965808-26-000013","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001965808-26-000013","line_url":"/filing/0001965808-26-000013#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001965808","owner_name":"Delaet Ingrid","owner_display_name":"Delaet Ingrid","owner_url":"/insider/0001965808","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4367.0,"shares_display":"4,367","price_per_share":181.02,"price_display":"181.02","price_state":"stated","total_value":790514.34,"total_display":"790,514.34","total_whole":"790,514","shares_owned_after":16225.0,"shares_owned_after_display":"16,225","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-10","filed_date":"2026-07-13","scope":"insider"},{"id":5760012,"accession":"0001965808-26-000011","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001965808-26-000011","line_url":"/filing/0001965808-26-000011#line-6","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001965808","owner_name":"Delaet Ingrid","owner_display_name":"Delaet Ingrid","owner_url":"/insider/0001965808","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8433.0,"shares_display":"8,433","price_per_share":178.7187,"price_display":"178.72","price_state":"stated","total_value":1507134.7971,"total_display":"1,507,134.80","total_whole":"1,507,135","shares_owned_after":16225.0,"shares_owned_after_display":"16,225","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-09","filed_date":"2026-07-09","scope":"insider"},{"id":5760010,"accession":"0001965808-26-000011","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001965808-26-000011","line_url":"/filing/0001965808-26-000011#line-4","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001965808","owner_name":"Delaet Ingrid","owner_display_name":"Delaet Ingrid","owner_url":"/insider/0001965808","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2737.0,"shares_display":"2,737","price_per_share":178.543,"price_display":"178.54","price_state":"stated","total_value":488672.191,"total_display":"488,672.19","total_whole":"488,672","shares_owned_after":16225.0,"shares_owned_after_display":"16,225","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-08","filed_date":"2026-07-09","scope":"insider"},{"id":5760008,"accession":"0001965808-26-000011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001965808-26-000011","line_url":"/filing/0001965808-26-000011#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001965808","owner_name":"Delaet Ingrid","owner_display_name":"Delaet Ingrid","owner_url":"/insider/0001965808","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3401.0,"shares_display":"3,401","price_per_share":178.5666,"price_display":"178.57","price_state":"stated","total_value":607305.0066,"total_display":"607,305.01","total_whole":"607,305","shares_owned_after":16225.0,"shares_owned_after_display":"16,225","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-07","filed_date":"2026-07-09","scope":"insider"},{"id":5913003,"accession":"0001965808-26-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001965808-26-000007","line_url":"/filing/0001965808-26-000007#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001965808","owner_name":"Delaet Ingrid","owner_display_name":"Delaet Ingrid","owner_url":"/insider/0001965808","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2261.0,"shares_display":"2,261","price_per_share":156.71,"price_display":"156.71","price_state":"stated","total_value":354321.31,"total_display":"354,321.31","total_whole":"354,321","shares_owned_after":16225.0,"shares_owned_after_display":"16,225","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-29","filed_date":"2026-06-02","scope":"insider"},{"id":4870870,"accession":"0000914475-25-000153","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-25-000153","line_url":"/filing/0000914475-25-000153#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001965808","owner_name":"Delaet Ingrid","owner_display_name":"Delaet Ingrid","owner_url":"/insider/0001965808","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":457.0,"shares_display":"457","price_per_share":135.0,"price_display":"135.00","price_state":"stated","total_value":61695.0,"total_display":"61,695.00","total_whole":"61,695","shares_owned_after":4730.0,"shares_owned_after_display":"4,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-10","filed_date":"2025-07-11","scope":"insider"},{"id":4043189,"accession":"0000914475-25-000061","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000914475-25-000061","line_url":"/filing/0000914475-25-000061","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001965808","owner_name":"Delaet Ingrid","owner_display_name":"Delaet Ingrid","owner_url":"/insider/0001965808","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1471.0,"shares_display":"1,471","price_per_share":116.7057268524813,"price_display":"116.71","price_state":"stated","total_value":171674.1242,"total_display":"171,674.12","total_whole":"171,674","shares_owned_after":4730.0,"shares_owned_after_display":"4,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-13","filed_date":"2025-02-14","scope":"insider","n_lines":2},{"id":4523435,"accession":"0000914475-25-000024","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000914475-25-000024","line_url":"/filing/0000914475-25-000024#line-4","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001965808","owner_name":"Delaet Ingrid","owner_display_name":"Delaet Ingrid","owner_url":"/insider/0001965808","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":623.0,"shares_display":"623","price_per_share":149.29,"price_display":"149.29","price_state":"stated","total_value":93007.67,"total_display":"93,007.67","total_whole":"93,008","shares_owned_after":3442.0,"shares_owned_after_display":"3,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-03","filed_date":"2025-02-04","scope":"insider"},{"id":4523425,"accession":"0000914475-25-000024","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-25-000024","line_url":"/filing/0000914475-25-000024#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001965808","owner_name":"Delaet Ingrid","owner_display_name":"Delaet Ingrid","owner_url":"/insider/0001965808","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":422.0,"shares_display":"422","price_per_share":153.0491,"price_display":"153.05","price_state":"stated","total_value":64586.7202,"total_display":"64,586.72","total_whole":"64,587","shares_owned_after":2886.0,"shares_owned_after_display":"2,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-31","filed_date":"2025-02-04","scope":"insider"},{"id":4294930,"accession":"0000914475-25-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-25-000002","line_url":"/filing/0000914475-25-000002#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001965808","owner_name":"Delaet Ingrid","owner_display_name":"Delaet Ingrid","owner_url":"/insider/0001965808","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":272.0,"shares_display":"272","price_per_share":138.1,"price_display":"138.10","price_state":"stated","total_value":37563.2,"total_display":"37,563.20","total_whole":"37,563","shares_owned_after":2507.0,"shares_owned_after_display":"2,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-31","filed_date":"2025-01-03","scope":"insider"},{"id":2138819,"accession":"0000914475-24-000224","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-24-000224","line_url":"/filing/0000914475-24-000224#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001965808","owner_name":"Delaet Ingrid","owner_display_name":"Delaet Ingrid","owner_url":"/insider/0001965808","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1091.0,"shares_display":"1,091","price_per_share":135.0,"price_display":"135.00","price_state":"stated","total_value":147285.0,"total_display":"147,285.00","total_whole":"147,285","shares_owned_after":2507.0,"shares_owned_after_display":"2,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-17","filed_date":"2024-12-19","scope":"insider"},{"id":2338719,"accession":"0000914475-24-000191","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000914475-24-000191","line_url":"/filing/0000914475-24-000191","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001965808","owner_name":"Delaet Ingrid","owner_display_name":"Delaet Ingrid","owner_url":"/insider/0001965808","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7143.0,"shares_display":"7,143","price_per_share":150.1022597648047,"price_display":"150.10","price_state":"stated","total_value":1072180.4415,"total_display":"1,072,180.44","total_whole":"1,072,180","shares_owned_after":2507.0,"shares_owned_after_display":"2,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-13","filed_date":"2024-08-15","scope":"insider","n_lines":2},{"id":2579530,"accession":"0000914475-24-000189","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-24-000189","line_url":"/filing/0000914475-24-000189#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001965808","owner_name":"Delaet Ingrid","owner_display_name":"Delaet Ingrid","owner_url":"/insider/0001965808","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":273.0,"shares_display":"273","price_per_share":147.7,"price_display":"147.70","price_state":"stated","total_value":40322.1,"total_display":"40,322.10","total_whole":"40,322","shares_owned_after":6607.0,"shares_owned_after_display":"6,607","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-06","filed_date":"2024-08-08","scope":"insider"},{"id":3150155,"accession":"0000914475-24-000174","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000914475-24-000174","line_url":"/filing/0000914475-24-000174","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001965808","owner_name":"Delaet Ingrid","owner_display_name":"Delaet Ingrid","owner_url":"/insider/0001965808","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2857.0,"shares_display":"2,857","price_per_share":150.02695134756738,"price_display":"150.03","price_state":"stated","total_value":428627.0,"total_display":"428,627.00","total_whole":"428,627","shares_owned_after":7507.0,"shares_owned_after_display":"7,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-16","filed_date":"2024-07-18","scope":"insider","n_lines":3},{"id":2764996,"accession":"0000914475-24-000164","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-24-000164","line_url":"/filing/0000914475-24-000164#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001965808","owner_name":"Delaet Ingrid","owner_display_name":"Delaet Ingrid","owner_url":"/insider/0001965808","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":272.0,"shares_display":"272","price_per_share":138.11,"price_display":"138.11","price_state":"stated","total_value":37565.92,"total_display":"37,565.92","total_whole":"37,566","shares_owned_after":7507.0,"shares_owned_after_display":"7,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-01","filed_date":"2024-07-02","scope":"insider"},{"id":2079533,"accession":"0000914475-24-000162","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-24-000162","line_url":"/filing/0000914475-24-000162#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001965808","owner_name":"Delaet Ingrid","owner_display_name":"Delaet Ingrid","owner_url":"/insider/0001965808","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":273.0,"shares_display":"273","price_per_share":136.55,"price_display":"136.55","price_state":"stated","total_value":37278.15,"total_display":"37,278.15","total_whole":"37,278","shares_owned_after":7507.0,"shares_owned_after_display":"7,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-31","filed_date":"2024-06-04","scope":"insider"},{"id":2671712,"accession":"0000914475-24-000119","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-24-000119","line_url":"/filing/0000914475-24-000119#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001965808","owner_name":"Delaet Ingrid","owner_display_name":"Delaet Ingrid","owner_url":"/insider/0001965808","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":273.0,"shares_display":"273","price_per_share":140.55,"price_display":"140.55","price_state":"stated","total_value":38370.15,"total_display":"38,370.15","total_whole":"38,370","shares_owned_after":7507.0,"shares_owned_after_display":"7,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-06","filed_date":"2024-05-08","scope":"insider"},{"id":2233484,"accession":"0000914475-24-000100","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-24-000100","line_url":"/filing/0000914475-24-000100#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001965808","owner_name":"Delaet Ingrid","owner_display_name":"Delaet Ingrid","owner_url":"/insider/0001965808","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":272.0,"shares_display":"272","price_per_share":137.3,"price_display":"137.30","price_state":"stated","total_value":37345.6,"total_display":"37,345.60","total_whole":"37,346","shares_owned_after":7507.0,"shares_owned_after_display":"7,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-03","scope":"insider"},{"id":2579516,"accession":"0000914475-24-000098","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-24-000098","line_url":"/filing/0000914475-24-000098#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001965808","owner_name":"Delaet Ingrid","owner_display_name":"Delaet Ingrid","owner_url":"/insider/0001965808","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":145.064,"price_display":"145.06","price_state":"stated","total_value":725320.0,"total_display":"725,320.00","total_whole":"725,320","shares_owned_after":7507.0,"shares_owned_after_display":"7,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-21","filed_date":"2024-03-25","scope":"insider"},{"id":2170846,"accession":"0000914475-24-000090","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-24-000090","line_url":"/filing/0000914475-24-000090#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001965808","owner_name":"Delaet Ingrid","owner_display_name":"Delaet Ingrid","owner_url":"/insider/0001965808","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":140.1398,"price_display":"140.14","price_state":"stated","total_value":420419.4,"total_display":"420,419.40","total_whole":"420,419","shares_owned_after":7507.0,"shares_owned_after_display":"7,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-13","filed_date":"2024-03-15","scope":"insider"},{"id":2300297,"accession":"0000914475-24-000086","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000914475-24-000086","line_url":"/filing/0000914475-24-000086#line-4","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001965808","owner_name":"Delaet Ingrid","owner_display_name":"Delaet Ingrid","owner_url":"/insider/0001965808","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":140.0,"price_display":"140.00","price_state":"stated","total_value":28000.0,"total_display":"28,000.00","total_whole":"28,000","shares_owned_after":7507.0,"shares_owned_after_display":"7,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-11","filed_date":"2024-03-12","scope":"insider"},{"id":2300290,"accession":"0000914475-24-000086","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-24-000086","line_url":"/filing/0000914475-24-000086#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001965808","owner_name":"Delaet Ingrid","owner_display_name":"Delaet Ingrid","owner_url":"/insider/0001965808","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":140.0292,"price_display":"140.03","price_state":"stated","total_value":252052.56,"total_display":"252,052.56","total_whole":"252,053","shares_owned_after":7507.0,"shares_owned_after_display":"7,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-08","filed_date":"2024-03-12","scope":"insider"},{"id":2976207,"accession":"0000914475-24-000084","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000914475-24-000084","line_url":"/filing/0000914475-24-000084#line-8","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001965808","owner_name":"Delaet Ingrid","owner_display_name":"Delaet Ingrid","owner_url":"/insider/0001965808","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":273.0,"shares_display":"273","price_per_share":135.51,"price_display":"135.51","price_state":"stated","total_value":36994.23,"total_display":"36,994.23","total_whole":"36,994","shares_owned_after":7507.0,"shares_owned_after_display":"7,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-29","filed_date":"2024-02-29","scope":"insider"},{"id":2976200,"accession":"0000914475-24-000084","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000914475-24-000084","line_url":"/filing/0000914475-24-000084","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001965808","owner_name":"Delaet Ingrid","owner_display_name":"Delaet Ingrid","owner_url":"/insider/0001965808","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6544.0,"shares_display":"6,544","price_per_share":135.33580378973105,"price_display":"135.34","price_state":"stated","total_value":885637.5,"total_display":"885,637.50","total_whole":"885,638","shares_owned_after":7507.0,"shares_owned_after_display":"7,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-28","filed_date":"2024-02-29","scope":"insider","n_lines":3},{"id":2170834,"accession":"0000914475-24-000071","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-24-000071","line_url":"/filing/0000914475-24-000071#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001965808","owner_name":"Delaet Ingrid","owner_display_name":"Delaet Ingrid","owner_url":"/insider/0001965808","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":716.0,"shares_display":"716","price_per_share":133.0346,"price_display":"133.03","price_state":"stated","total_value":95252.7736,"total_display":"95,252.77","total_whole":"95,253","shares_owned_after":7507.0,"shares_owned_after_display":"7,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-13","filed_date":"2024-02-15","scope":"insider"},{"id":2107012,"accession":"0000914475-24-000026","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-24-000026","line_url":"/filing/0000914475-24-000026#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001965808","owner_name":"Delaet Ingrid","owner_display_name":"Delaet Ingrid","owner_url":"/insider/0001965808","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":623.0,"shares_display":"623","price_per_share":139.77,"price_display":"139.77","price_state":"stated","total_value":87076.71,"total_display":"87,076.71","total_whole":"87,077","shares_owned_after":6865.0,"shares_owned_after_display":"6,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-01","filed_date":"2024-02-02","scope":"insider"},{"id":2107009,"accession":"0000914475-24-000026","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-24-000026","line_url":"/filing/0000914475-24-000026#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001965808","owner_name":"Delaet Ingrid","owner_display_name":"Delaet Ingrid","owner_url":"/insider/0001965808","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":422.0,"shares_display":"422","price_per_share":141.94,"price_display":"141.94","price_state":"stated","total_value":59898.68,"total_display":"59,898.68","total_whole":"59,899","shares_owned_after":6309.0,"shares_owned_after_display":"6,309","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-31","filed_date":"2024-02-02","scope":"insider"},{"id":8116576,"accession":"0001209191-23-047747","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-047747","line_url":"/filing/0001209191-23-047747#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001965808","owner_name":"Delaet Ingrid","owner_display_name":"Delaet Ingrid","owner_url":"/insider/0001965808","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1431.0,"shares_display":"1,431","price_per_share":107.52,"price_display":"107.52","price_state":"stated","total_value":153861.12,"total_display":"153,861.12","total_whole":"153,861","shares_owned_after":5931.0,"shares_owned_after_display":"5,931","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-28","filed_date":"2023-08-30","scope":"insider"},{"id":7816320,"accession":"0001209191-23-047134","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-047134","line_url":"/filing/0001209191-23-047134#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001965808","owner_name":"Delaet Ingrid","owner_display_name":"Delaet Ingrid","owner_url":"/insider/0001965808","role":"Officer (Chief Regulatory Officer)","role_mark":"O","role_mark_label":"Officer (Chief Regulatory Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Regulatory Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1404.0,"shares_display":"1,404","price_per_share":107.4219,"price_display":"107.42","price_state":"stated","total_value":150820.3476,"total_display":"150,820.35","total_whole":"150,820","shares_owned_after":4645.0,"shares_owned_after_display":"4,645","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-21","filed_date":"2023-08-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":35,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":35,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":35},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000914475","name":"NEUROCRINE BIOSCIENCES INC","url":"/issuer/0000914475","role":"Officer (Chief Regulatory Officer)","n_filings":23,"first_seen":"2023-08-23","last_seen":"2026-07-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001965808","retrieved_at":"2026-08-26T19:31:17+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}